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Abstract 
Recent guidelines adapted unique pregnancy thyroid function screening tests because pregnancy subclinical 
hypothyroidism is associated with different adverse outcomes.  There are no data from Iraq about the prevalence of 
thyroid hypo function in 1st trimester of  pregnancy. This study aims to find the prevalence of thyroid dysfunction 
in 1st trimester.                                               
Patients and Methods: In this descriptive cross sectional study, thyroid stimulating hormone (TSH) was 
measured in 100 pregnant women from  May 2017-December 2017 in Babylon teaching hospital for maternity and 
pediatric and in private clinic. If TSH was more than 2.5 mIU/L in the first trimester, free T4 was measured to 
diagnose then differentiate between subclinical & overt hypothyroidism. If free T4 was in the normal value (0.7-
1.8 ng/dl) the diagnosis was subclinical hypothyroidism and if below the normal value, overt hypothyroidism was 
diagnosed. 
Results 
 A total of 100 pregnant women were evaluated. Twenty-eight of them were diagnosed as hypothyroidism. 
Subclinical hypothyroidism and overt hypothyroidism were present in 24 (24%) and 4 (4%) women respectively. 
Most of the subclinical and overt hypothyroidism cases were diagnosed in the first trimester. 
1- Introduction 
There are different studies which show decreased intellectual and motor development of babies is associated 
with abnormalities of their mothers thyroid function [1, 2]. Thyroid gland disorders are one of the common 
endocrine problems in pregnant ladies. It is now well known that not only overt, but also subclinical 
hypothyroidism (SCH) has adverse side effects on maternal and fetal outcome [1]. Fetal thyroid gland is not 
working up to 12 weeks of gestation. Thyroid releasing hormone crosses the placenta to stimulate fetal thyroid 
gland. So maternal thyroid function is very important during the first trimester [4]. During the first trimester, 
human chorionic gonadotropin (hCG) level is elevated that act similar to thyroid stimulating hormone (TSH) (α 
subunit of hCG and TSH is similar). So the effect of TSH, under the influence of placental hCG, is low during 
pregnancy with the decreased TSH level in the first trimester beings poorly defined and an upper level of 2.5 
mIU/L. At 10-12 weeks of gestation, plasma level of hCG begins to decline to act like TSH, so TSH is increased a 
little to an upper normal level of 3mIU/L in the second and third trimester[4]. However, a study in Iraq  stated that 
TSH level did not show significant differences in different trimesters of pregnancy. There is no data from Iraq 
about the prevalence of SCH in pregnancy and there is debate about unique screening of thyroid function tests in 
pregnancy. We, therefore, studied the thyroid function of pregnant ladies to know the prevalence of subclinical 
cases of hypothyroidism. 
2- Patients and Methods:  
This descriptive cross-sectional study was done on 100 pregnant ladies in Babylon teaching  hospital for 
maternity and pediatrics in Alilla city and in private clinic , Babylon university  of Medical Sciences  . For all 
pregnant ladies from  May 2017-December 2017   during routine laboratory workup, screening of thyroid function 
tests was done by TSH level in the endocrine laboratory  by the chemiluminescent immunoassay (Elecsys 2010, 
Hitachi, Diamond, Japan). If TSH level was >2.5 mIU/L in the first trimester or TSH >3 mIU/L in the second or 
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third trimester, free T4 measurement was done by chemiluminescent immunoassay to know whether it is 
subclinical or overt hypothyroidism. If serum FT4 was in the normal range (0.8-1.7 ng/dl) SCH was diagnosed and 
if below the normal range, overt hypothyroidism was the diagnosis. Their demographic (maternal age, gestational 
age, parity ,BMI, residence) and clinical details were collected as part of routine antenatal care and were recorded. 
We asked the women about personal and family history of thyroid disease. Duration of gestation was calculated 
from last menstrual period and verified by ultrasonography. Informed consent was taken from all participants. 
SPSS software version 20 was used for data analysis. 
 
3- Results 
Table1shows that the mean age of pregnant women who participated in the study is 
26.32±6.04years.Regarding body mass  index and weeks of gestation, the mean is  29.12±3.46kg/m2 and 
8.0±2.06weeks respectively. Over half of pregnant women (60.0%) reside in urban areas while (40.0%) reside in 
rural areas .Up to 64.0% 0f pregnant women are multigravida. 
 
Table 1:Distribution of the pregnant mothers according to age, BMI, GA, parity  and residence. 
Variables 
Age (years)     
 
26.32±6.04 (16-40) 
BMI (kg/m2) 29.12±3.46 (24-38) 
Weeks of gestation (week) 8.0±2.06 (4-12) 
Residence 
Urban 
Rural 
Total 
 
60 
40 
100 
 
60.0% 
40.0% 
100.0% 
Parity 
Primigravida 
Multigravida 
Total 
 
36 
64 
100 
 
36.0% 
64.0% 
100.0% 
 
 
Table 2 shows that the mean of thyroid stimulating hormone (TSH) and free T4 is 2.49±0.82 and 1.07±0.3 
respectively. 
 
Table 2: Distribution of the pregnant mothers according to TSH and FT4. 
Variable Mean±SD Range 
TSH*(U/ml) 2.49±0.82 (1.6-4.8) 
FT4** (ng/dl) 1.07±0.3 (0.5-1.8) 
*TSH: .Thyroid stimulating hormone .    **FT4:Free T4. 
 
Figure 1 shows that subclinical hypothyroidism represents 24.0% of the total pregnant mothers in the first 
trimester who participated in the study while 4.0% have overt hypothyroidism.  
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Figure 1: Distribution of pregnant mothers according to the diagnosis of hypothyroidism. 
 
Table 3 shows that fisher exact test was conducted to show the association between parity, residence with the 
diagnosis of hypothyroidism. There is a significant association between residence and diagnosis (p-value <0.001) 
 
Table 3: Association between parity, residence and diagnosis of hypothyroidism. 
Variables Diagnosis Total P- value 
Normal Subclinical Overt 
 
Parity 
Primigravida 
Multigravida 
Total 
 
24(33.3%)          12(50.0%)       0(0.0%) 
48(66.7%)          12(50.0%)       4(100.0%) 
72(100.0%)        24(100.0%)     4(100.0%) 
 
36(36.0%) 
64(64.0%) 
100(100.0%) 
 
0.1f 
 
Residence 
Urban 
Rural 
Total 
 
52(72.2%)           8(33.3%)         0(0.0%) 
20(27.8%)           16(66.7%)        4(100.0%) 
72(100.0%)         24(100.0%)      4(100.0%) 
 
60(60.0%) 
40(40.0%) 
100(100.0%) 
 
<0.001*f 
*P- value≤ 0.05 was significant.      f:fisher-exact test. 
 
In this table, F-test (ANOVA) was conducted to show if there were mean differences of age ,BMI and weeks 
of gestation according to diagnosis of hypothyroidism( normal ,subclinical or overt ).In all circumstances there 
were significant mean differences (p-value <0.001*) 
 
 
 
 
 
 
 
 
 
 
0%
20%
40%
60%
80%
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Overt
72% 
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4% 
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Table 4: Mean difference of age , BMI and GA according to diagnosis of hypothyroidism in pregnant 
women. 
*P- value≤ 0.05 was significant. 
 
Figure 2 :-This figure shows that there was a significant negative linear correlation between TSH and FT4(p-value 
= 0.011*, r = - 0.252 ) 
 
Figure 2: Correlation between TSH and FT4. 
 
Figure 3 depicts that there was a significant mean difference of TSH according to age,(p-value =0.006).Regarding 
FT4 also there was a significant mean difference according to age ,(p value =0.03) 
 
Variable Study groups N Mean±SD F- test P-value 
Age (year) Normal 
Subclinical 
Overt 
72 
24 
4 
26.89±5.67 
22.33±2.8 
40.0±0.0 
22.66 <0.001* 
BMI (kg/m2) Normal 
Subclinical 
Overt 
72 
24 
4 
 
28.06±2.77 
30.83±2.72 
38.0±0.0 
31.52 <0.001* 
Week of gestation(week) Normal 
Subclinical 
Overt 
 
72 
24 
4 
 
7.11±1.49 
10.17±1.6 
11.0±0.0 
45.63 <0.001* 
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Figure 3: Distribution of TSH and FT4 according to the age of the pregnant mothers. 
 
Figure 4 depicts the higher percentage of subclinical cases of hypothyroidism was present in women aged 20- 35 
years (83.3%),while those aged younger than 20 years ,the percentage was 16.7% 
 
 
 
Figure 4: Association between age of the pregnant women and diagnosis. 
 
4-Discussion 
We found the prevalence of subclinical hypothyroidism to be 6.15%. According to the study by Casey et al. the 
prevalence of subclinical hypothyroidism during early pregnancy is common, affecting about 5.5% pregnant 
women [7, 8]. A similar result was reported by Allan et al. [9], Vaidya et al. [10] and Mannisto et al. [11]. These 
studies are in contrast with the report by Gillett who stated that routine screening of pregnant women is not 
necessary for thyroid function, unless they were at increased risk of thyroid disease [12]. 
This suggests that subclinical hypothyroidism is more common in pregnant women especially in Iraqi pregnant 
ladies. Subclinical hypothyroidism during early pregnancy has been shown to be associated with the impaired 
neuropsychological development of children and several other adverse outcomes, including preterm delivery, 
preeclampsia and increased fetal mortality [1,4, 8, 10, 11, 13-16]. But the study by Cleary Goldman et al. showed 
that subclinical hypothyroidism is detectable in 2.2% in the first and second trimesters with no adverse outcome in 
pregnant women with thyroid hypofunction [15]. Pregnancy has much influence on the thyroid gland and thyroid 
0%
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function. Physiological changes of pregnancy cause the thyroid gland to increase production of thyroid hormones 
to meet maternal and fetal needs. TSH and human chorionic gonadotropin (hCG) have identical α subunits 
whereas the β subunits differ in their amino acid sequence[4]. There is also an uncertainty regarding the most 
appropriate initial screening test for thyroid dysfunction in pregnancy. The consensus guidelines recommend using 
TSH level as the initial test [10, 14,16]. The American College of Obstetricians and Gynecologists (2007) 
concluded that although observational data were consistent with the possibility that subclinical hypothyroidism 
was associated with adverse neuropsychological development, there have been no interventional trials to 
demonstrate improvement in decision to do routine thyroid screening of pregnant women. There are reports that 
testing the high-risk group only for thyroid function would miss about one third of pregnant women with 
overt/subclinical hypothyroidism [7, 9, 17-22]. Most of our patients with overt hypothyroidism were diagnosed in 
the first trimester. This is in agreement with a previous study by Sahu et al. in India in which the rate of overt 
hypothyroidism was reported as 4.6% [3]. We know that patients with overt hypothyroidism usually are infertile 
and if they become pregnant, complications of pregnancy such as abortion may occur. So universal screening for 
thyroid function appears logical. Also, diagnosis of subclinical hypothyroidism during the third trimester is 
necessary to treat them and prevent postpartum depression. 
 
5- Conclusion 
There is a high percentage of pregnant women that reach second and third trimester of pregnancy with 
undiagnosed thyroid disease. It is , therefore, necessary to screen women with a serum TSH, if they are pregnant or 
deciding to become pregnant to overcome the complications that may occur due to maternal hypothyroidism. 
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